BRIEF published on 09/05/2025 at 14:35, 4 months 26 days ago Wellgistics Health to Present at Key September Investor Conferences Investor Conferences AI-driven Solutions Pharmaceutical Distribution Wellgistics Health Brian Norton
PRESS RELEASE published on 09/05/2025 at 14:30, 4 months 26 days ago Wellgistics Health, Inc. to Present at September Investor Conferences Wellgistics Health to present at three investor conferences in September 2025 to showcase strategic vision and innovations. CEO Brian Norton emphasizes importance of visibility and engagement Investor Conferences Future Growth Pharmaceutical Distribution Wellgistics Health AI-powered Hub Fulfillment
BRIEF published on 08/27/2025 at 14:05, 5 months 5 days ago Wellgistics Health Launches HubRx AI to Revolutionize Prescription Services Healthcare Automation Wellgistics Health HubRx AI AI-powered Prescription Pharma Market
PRESS RELEASE published on 08/27/2025 at 14:00, 5 months 5 days ago Wellgistics Health Introduces HubRx AI: Advancing the AI-Powered Prescription Ecosystem Wellgistics Health introduces HubRx AI, a customizable AI engine for prescription hub services, aiming to streamline operations and enhance patient outcomes Patient Outcomes Wellgistics Health HubRx AI AI Engine Prescription Hub Services
BRIEF published on 08/20/2025 at 15:05, 5 months 12 days ago Wellgistics Health Reports Stability and Growth Initiatives in Mid-2025 Financial Results Growth Initiatives Wellgistics Health Operational Integration Direct-to-Patient
PRESS RELEASE published on 08/20/2025 at 15:00, 5 months 12 days ago Wellgistics Health Achieves Stability in First-Half 2025 and Executes Growth Initiatives Wellgistics Health, Inc. announces financial results for the second fiscal quarter ending June 30, 2025. Transformational progress and strategic initiatives highlighted Financial Results Strategic Initiatives Wellgistics Health Direct-to-Patient Transformational Progress
BRIEF published on 08/14/2025 at 14:35, 5 months 18 days ago Wellgistics Health Ends Equity Line of Credit to Focus on Growth Growth Strategy AI Technology Pharmaceutical Distribution Wellgistics Health Equity Line Termination
PRESS RELEASE published on 08/14/2025 at 14:30, 5 months 18 days ago Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy Wellgistics Health terminates equity purchase agreement with Hudson Global Ventures, LLC to focus on long-term shareholder value. Strategic shift towards accretive financing and growth opportunities Shareholder Value Termination Equity Purchase Agreement Wellgistics Health Accretive Financing
BRIEF published on 07/25/2025 at 13:50, 6 months 7 days ago Wellgistics Health Converts $8.1M Debt to Equity Shareholder Value AI Technology Pharmaceutical Distribution Debt-to-equity U.S. Healthcare
PRESS RELEASE published on 07/25/2025 at 13:45, 6 months 7 days ago Wellgistics Health Converts $8.1M Debt to Equity Wellgistics Health approves $8.1 million debt-to-equity conversion to enhance financial position and accelerate growth, aiming to transform the prescription drug marketplace Financial Growth Pharmaceutical Distribution Debt-to-equity Conversion Wellgistics Health AI-powered Hub Fulfillment
Published on 01/31/2026 at 03:15, 1 day 11 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 13 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 16 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 23 hours 19 minutes ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 2 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 12 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 17 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 19 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 17:45, 1 day 21 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 2 days 21 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 2 days 21 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 2 days 21 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025
